Vorsitz: M. W. Bergmann (Hamburg), K.-H. Kuck (Hamburg)
| (V1576) | Renal Dysfunction is a Potent Predictor of Stroke and Systemic Embolism Among Individuals with Atrial Fibrillation: Results from the ROCKET AF Trial |
| G. Breithardt, J. P. Piccini, S. R. Stevens, M. Patel, K. Mahaffey, J. Paolini, C. C. Nessel, R. C. Becker, J. Halperin, W. Hacke, D. Singer, G. Hankey, K. Fox, R. Califf (Münster, Heidelberg; Durham, Montville, Raritan, New York, Boston, US; Perth, AU; Edinburgh, UK) | |
| (V1577) | Oral anticoagulation (INR) does not correlate with Activated Clotting Time (ACT) at the beginning of left atrial ablation procedures |
| T. Reents, H. Pavaci, A. Hinz, S. Ammar, S. Fichtner, C. Jilek, S. Kathan, P. Zhu, V. Semmler, C. Lennerz, C. Kolb, G. Heßling, I. Deisenhofer (München) | |
| (V1578) | Ischemic Cardiac Outcomes in Patients with AF Treated with Vitamin K Antagonism or Factor Xa Inhibition: Results from the ROCKET AF Trial |
| C. Bode, K. Mahaffey, H. White, C. C. Nessel, S. G. Goodman, J. P. Piccini, M. Patel, J. Paolini, R. C. Becker, J. Halperin, W. Hacke, D. Singer, G. Hankey, R. Califf, K. Fox, G. Breithardt (Freiburg im Breisgau, Heidelberg, Münster; Durham, Raritan, Montville, New York, Boston, US; Auckland, NZ; Toronto, CA; Perth, AU; Edinburgh, UK) | |
| (V1579) | Risk factor distribution and stroke risk in AF in the general population |
| R. Schnabel, S. Wilde, P. S. Wild, T. Münzel, S. Blankenberg (Hamburg, Mainz) | |
| (V1580) | LAA Occlusion Using the Watchman Device in a High Risk Population: Is There a Significant Risk of Periprocedural Cerebral Stroke or Microembolism? |
| A. Schade, J. Krug, C. Stahl, G.-A. Szöllösi, S. Fodor, R. Schmitt, V. Ziegler, H. Soda, T. Deneke (Bad Neustadt a. d. Saale) | |
| (V1581) | ALSTER-LAA Register: Prozedurale Details bei Implantation des WATCHMAN Devices zum interventionellen Verschluss des linken Vorhofsohres |
| F. Meincke, M. Schmidt-Salzmann, F. Kreidel, K.-H. Kuck, M. W. Bergmann (Hamburg) |